Wedell-Wedellsborg Johan
SEC insider (Form 3/4/5 filer). CIK 0001753185. Director & 10% Owner at Y-mAbs Therapeutics, Inc. (YMAB). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2025. Located in NEW YORK, NY.
Companies Wedell-Wedellsborg Johan has filed insider reports for
- Y-mAbs Therapeutics, Inc. (YMAB): Director, 10% Owner
Wedell-Wedellsborg Johan
CIK: 0001753185
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
YMAB
Y-mAbs Therapeutics, Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 16, 2025YMAB
Y-mAbs Therapeutics, Inc.
Tender OfferDirect5.8K shares at avg. $8.60$50K - Sep 16, 2025YMAB
Y-mAbs Therapeutics, Inc.
DispositionDirect25.1K shares- - Sep 16, 2025YMAB
Y-mAbs Therapeutics, Inc.
Tender OfferIndirect4.6M shares at avg. $8.60$39.2M - Jun 30, 2025YMAB
Y-mAbs Therapeutics, Inc.
AwardDirect25.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Tender Offer | 5,825 | $8.60 | $50,095 | Direct |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Disposition | 25,080 | - | - | Direct |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Tender Offer | 4,559,233 | $8.60 | $39,209,404 | Indirect |
| Jun 30, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Award | 25,080 | - | - | Direct |
1-4 of 4 transactions